Business Investment Opportunities

- A biotech firm based in Milan, focusing on cancer immuno personalized therapy. - Has a portfolio of R&D projects and two Finished Dosage Forms (FDF) in the Italian market, including Aripiprazole and Emtricitabine + Tenofovir. - The company specializes in the development of microfluidic technology for the production and purification of Exosomes, with applications in anti-inflammatory, skin regenerative, anti-acne and atopic dermatitis, scalp rejuvenation, and hair growth treatments. - Exosomes, a key product of the company, are body-identical ingredients known for their high stability and low likelihood of causing adverse reactions. Their cell-penetrating mechanism enables them to deliver regeneration signals, making them suitable for diverse medical and cosmetic applications. - Has 3 major clients and supplied on a quarterly basis to pharmaceutical companies in Italy, Poland, and Brazil. - Operates with a network of 12 agents in addition to its 3 permanent employees. - Collaborates with Contract Manufacturing Organizations (CMOs) for the production of its pharmaceutical products. The company holds essential regulatory licenses from GMP, FDA, and the Ministry of Health, ensuring compliance with international quality and safety standards.

- We have online shops for B2B & B2C customers in the following countries- Italy, Denmark, Netherlands, Germany, Austria, Estonia, Slovenia, and Sweden. - We have important brand contracts for distributing their products in the EU. - Our company has a proven track record of distributing high-quality products from around the world. - Have partnership with over 4 companies to distribute the beverages.

- The company is a fully integrated Ready to Cook, D2C startup delivering premium imported ingredients in the form of DIY kits to simplify cooking Global recipes right at your home. Key Business Highlights: * Revenue has grown exponentially 24X in the last 2 Months. * 70%+ Gross Margin. * 8,000+ kits delivered, pan India. * First mover in the segment and space. * Completely asset lite model. * Have over 9 SKUs currently expanding to 2 new SKUs every month. * Non-perishable ingredients with kits ranging with shelflife from 6 months to 1 Year.

- SaaS platform to create e-commerce and digital business solutions instantly on Cloud. - The project is early stage and currently catering to 7+ clients who are on-boarded and started on early access to the platform. - We generate revenue by charging subscription fees (depending on SKUs). - Discovery focuses on providing a general business digital solution for small and medium businesses. - Will help entrepreneurs create digital solutions for business and e-commerce independently and quickly. It helps them to reduce the Capex and Opex and also helps them to reduce the technology dependencies. - The company was established 3 years ago but the revenue generation started recently. - The company is expected to 20x growth and the company's business plan and market have the potential to achieve 50M USD in 4-5 years. - We also have around 50 employees who work on the development side of our products, and we have a few freelancers who help with marketing as well.

- Business is revolutionizing the management of chronic and neuropathic pain in India with a focus on safety and efficacy. - Our licensed healthcare company is pioneering the country's first range of GMP-compliant, lab-certified, ayurvedic cannabinoid formulations designed to provide patients with a natural alternative to traditional pain medications. - First mover advantage: First to bring cannabinoid based pain management solutions into mainstream healthcare and retail in India. - Onco Range: Launched India's first and only Onco-focused range of CBD formulations addressing big problem areas in cancer care. - Endorsement from the medical community: Extensive inroads into the medical community with KOL's prescribing and endorsing our medications. - Backed by clinical trials: 1st Indian company to conduct clinical trials and bring CBD-based pain management products into mainstream healthcare and retail. - Extensive distribution: Access to extensive distribution through partnerships with the largest healthcare and big box companies such as Apollo, Guardian, Genisan Healthcare, Max Group, Spencer’s Retail, and Nature Basket. - Traction: Since last year, 9X growth in Offline sales and 3X growth in sales. - Marquee investors onboarded from Apollo Hospital, Panthera Peak Ventures, IIFL Finance,  Mahindra First. - The business has all the required licenses and certifications.

At the company the belief is that business success must harmonize with environmental and social responsibility. The vision is not just to create products; but it's about crafting a legacy—a legacy of sustainability, innovation, and positive change. The company has been a pioneer in India’s sustainable growth story since 2018. They have proudly contributed to India’s inclusive growth story and circular economy. · 1st brand in India to use plant-based leather alternatives since 2018. · 1st multi-category sustainable & craft-based fashion brand. Key business highlights: · Innovative vegan materials: 1st Brand to use plant-based leather alternatives such as Piñatex, Apple leather, Cactus leather, SI leather and many more innovative materials. ·Promoting Indian crafts: They promote and use traditional Indian crafts such as Kalamkari, Lambani, Mirzapuri, Shibori, Jaipuri, Chikankari, Bagru, Kutch etc. · Impact-driven: They now work with 100+ artisans directly contributing to sustaining their crafts and livelihoods. · Large addressable markets: The company's AOV ranges between INR 2,500 to 3,000. · Omnichannel brand: They have opened their flagship premium store at a huge mall in Pune tapping into the offline market. 2 new stores in Mumbai and Bangalore planned in this FY. · Proven product market fit: They have proudly crossed 50K + customers and is growing. They have expanded their product portfolio from one category (bags) to 4 categories (bags, men & women clothing and footwear) making it an end-to-end fashion brand. · High margins: They have maintained consistent high gross margins (60% +) and have grown 4x in revenues in just 2 years. · Path to profitability: Their cash burns have nearly come down to almost NIL and will turn profitable within 2 months.

- Vertically integrated mega cannabis industrial park business located in the San Francisco Bay Area. - The business model primarily focuses on the development of greenhouses for cannabis cultivation on owned land. - The project has received endorsement from the city mayor, and all Conditional Use Permits (CUPs) have been issued. Pilot programs have been successfully completed, affirming the profitability potential through retail outlets. - The vertical integration of the business, in combination with the real estate component, significantly reduces risk. The land value, at full use, is estimated to be approximately $100 million. - The projected revenues for the business are expected to reach $500 million post complete development. The model and permitted site plans of the business can be duplicated, as evidenced by inquiries from mayors of other cities. - The business holds 22 cannabis permit licenses and operates in both B2C and B2B segments. It generates 80% of its revenue from B2C sales through two retail outlets and a kiosk, while the remaining 20% is derived from B2B through wholesale. - There are currently 10 permanent employees, who manage the business operations.

- Over 5,600 clients of which around 50% are returning clients. 60 companies and large international firms are utilizers. - Products: in-person and online services such as osteopathy, massages, motherhood courses, psychological support, physio & training, and company safety courses. Dedicated customer care by the company staff. - Markup: up to ca. 50% on B2B and up to ca. 30% on B2C. - Sales channels: a proprietary platform for booking, sales management, and listed professionals to self-advertise. Services are offered both wholesale (B2B) or single session/retail (B2C) - Main IP: Recognised brand, copyrighted software.